D
Dogwood Therapeutics, Inc. (DWTX)
NCM – Real Time Price. Currency in USD
1.65
+0.17 (11.49%)
At close: Jun 26, 2026, 4:00 PM EDT
1.52
-0.13 (-7.88%)
After-hours: Jun 26, 2026, 7:46 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.65
+0.17 (11.49%)
At close: Jun 26, 2026, 4:00 PM EDT
1.52
-0.13 (-7.88%)
After-hours: Jun 26, 2026, 7:46 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $13.2M significantly exceed its total debt $144.9K, ensuring strong financial flexibility
Total current assets $15.0M exceed Total current liabilities $2.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.86 | 6.05 | 10 | |
| Quick ratio | 5.86 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | -12K | -68K | -68K |
| Operating Income | -12M | -5M | -12M | -28M | -29M |
| Net Income | -12M | -5M | -12M | -34M | -28M |
| EBITDA | -12M | -5M | -12M | -28M | -29M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 93.13 | 5.5 |
| Next quarter | N/A | 98.21 | 5.5 |
| Current year | N/A | 91.8 | 5.5 |
| Next year | N/A | -27.35 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -31.9 | 42.31 | -26.11 | 5.5 |
| Y/Y | 999 | 54.36 | 98.22 | 2.04 | 8.3 |
| 3y average | 999 | -84.59 | 12.99 | -33.53 | 5.0 |
| 5y average | 999 | -56.95 | 17.95 | -75.29 | 5.3 |
| Weighted average score | 6.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |